Bile duct neoplasm

Related records

Broader conditions (18)

• Bile duct disorder
• Biliary tract disorder
• Biliary tract neoplasm
• Cancer or benign tumor
• Digestive system disorder
• Digestive system neoplasm
• Disease
• Disease by body system or component
• Disease by etiologic mechanism
• Endocrine gland neoplasm
• Endocrine system disorder
• Hepatobiliary disorder
• Hepatobiliary neoplasm
• Human disease
• Liver and intrahepatic bile duct neoplasm
• Liver disorder
• Neoplasm
• Neoplastic disease or syndrome

Narrower conditions (65)

• Adenocarcinoma of gallbladder and extrahepatic biliary tract
• Adenosquamous bile duct carcinoma
• Ampulla of vater adenocarcinoma
• Ampulla of vater adenosquamous carcinoma
• Ampulla of vater cancer
• Ampulla of vater clear cell adenocarcinoma
• Ampulla of vater mucinous adenocarcinoma
• Ampulla of vater neoplasm
• Ampulla of vater small cell neuroendocrine carcinoma
• Ampulla of vater squamous cell carcinoma
• Ampullary signet ring cell adenocarcinoma
• Bile duct adenocarcinoma
• Bile duct adenoma
• Bile duct cancer
• Bile duct carcinoma
• Bile duct carcinoma in situ
• Bile duct cystadenoma
• Bile duct mucinous cystic neoplasm with an associated invasive carcinoma
• Bile duct papillary neoplasm
• Bile duct sarcoma

Trials (250)

• 7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007)
• A Clinical Trail of KJ015 in Patients With HER2-Expressing Solid Tumors
• A Clinical Trial Targeting CEA Chimeric Antigen Receptor T (CAR-T) for CEA Positive Advanced Malignant Solid Tumors
• A Clinical Trial to Evaluate Safety and Efficacy of Endovascualr Denervation in Treatment of Cancer Pain
• A Clinical Trial to Test if the Investigational Drug BNT329 is Safe and Potentially Beneficial for People With Advanced Solid Tumors Known to Express the Tumor Marker CA19-9
• A Dual Channel Supraglottic Airway Device (LMA Gastro) for Oxygenation in Patients Undergoing ERCP
• A Phase 1/2 Safety Study of Intratumorally Dosed INT230-6
• A Phase 1/2a Study of DB-1303/BNT323 in Advanced/Metastatic Solid Tumors
• A Phase 1a/1b Study of ACTM-838 in Patients With Advanced Solid Tumors
• A Phase 2 Trial of Regorafenib as A Single Agent in Advanced and Metastatic Biliary Tract Carcinoma/Cholangiocarcinoma Patients Who Have Failed First-line Chemotherapy
• A Phase I/II Safety and Efficacy Study of PCI of Gemcitabine and Chemotherapy in Patients With Cholangiocarcinomas
• A Pilot Study of Combined Immune Checkpoint Inhibition in Combination With Ablative Therapies in Subjects With Hepatocellular Carcinoma (HCC) or Biliary Tract Carcinomas (BTC)
• A Randomized, Open, Prospective Clinical Research of Fluorouracil Implant to Improve Surgical Gallbladder Cancer and Bile Duct Cancer
• A Registry of Patients Undergoing Cellvizio Endomicroscopy and Endoscopic Retrograde Cholangiopancreatography(ERCP) Imaging Procedures for Diagnosing Pancreatic and Bile Duct Cancers
• A Single-center, Prospective Cohort Study on the Differentiation of Benign and Malignant Bile Duct Stenosis Based on Bile and Peripheral Blood cfDNA Methylation Profiles
• A Study of CDX-1140 (CD40) as Monotherapy or in Combination in Patients With Advanced Malignancies
• A Study of CDX-1140, a CD40 Agonist, in Combination With Capecitabine and Oxaliplatin (CAPOX) and Keytruda in Subjects With Biliary Tract Carcinoma (BTC)
• A Study of CF33-hNIS (VAXINIA), an Oncolytic Virus, as Monotherapy or in Combination With Pembrolizumab in Adults With Metastatic or Advanced Solid Tumors
• A Study of ELI-002 in Subjects With KRAS Mutated Pancreatic Ductal Adenocarcinoma (PDAC) and Other Solid Tumors
• A Study of FT-2102 in Patients With Advanced Solid Tumors and Gliomas With an IDH1 Mutation